Optas LLC Invests $218,000 in Align Technology, Inc. $ALGN

Optas LLC purchased a new position in shares of Align Technology, Inc. (NASDAQ:ALGN) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 1,151 shares of the medical equipment provider’s stock, valued at approximately $218,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Teacher Retirement System of Texas purchased a new stake in shares of Align Technology during the 1st quarter worth about $1,647,000. Asset Management One Co. Ltd. raised its stake in shares of Align Technology by 14.5% during the 1st quarter. Asset Management One Co. Ltd. now owns 31,624 shares of the medical equipment provider’s stock worth $5,024,000 after purchasing an additional 4,009 shares in the last quarter. Czech National Bank raised its stake in shares of Align Technology by 3.3% during the 2nd quarter. Czech National Bank now owns 16,654 shares of the medical equipment provider’s stock worth $3,153,000 after purchasing an additional 537 shares in the last quarter. Acadian Asset Management LLC purchased a new stake in shares of Align Technology during the 1st quarter worth about $20,194,000. Finally, Parallel Advisors LLC raised its stake in shares of Align Technology by 66.0% during the 2nd quarter. Parallel Advisors LLC now owns 1,044 shares of the medical equipment provider’s stock worth $198,000 after purchasing an additional 415 shares in the last quarter. 88.43% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on ALGN. Wells Fargo & Company cut their price target on Align Technology from $246.00 to $199.00 and set an “overweight” rating for the company in a research note on Thursday, July 31st. Mizuho set a $210.00 price objective on Align Technology in a research note on Thursday, July 31st. Weiss Ratings downgraded Align Technology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday. Evercore ISI cut their price objective on Align Technology from $170.00 to $160.00 and set an “outperform” rating on the stock in a research note on Wednesday. Finally, Piper Sandler cut their price objective on Align Technology from $250.00 to $190.00 and set an “overweight” rating on the stock in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $200.00.

Align Technology Stock Down 4.6%

Shares of NASDAQ ALGN opened at $125.79 on Friday. The business’s 50 day moving average is $135.61 and its two-hundred day moving average is $164.40. The company has a market cap of $9.12 billion, a P/E ratio of 21.21, a P/E/G ratio of 1.50 and a beta of 1.70. Align Technology, Inc. has a 12 month low of $122.00 and a 12 month high of $246.19.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing the consensus estimate of $2.57 by ($0.08). The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1.06 billion. Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The business’s quarterly revenue was down 1.6% on a year-over-year basis. During the same period in the prior year, the firm earned $2.41 earnings per share. Align Technology has set its Q3 2025 guidance at EPS. Sell-side analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology announced that its board has initiated a share repurchase plan on Tuesday, August 5th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to purchase up to 2% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s management believes its stock is undervalued.

Insider Buying and Selling

In other Align Technology news, CEO Joseph M. Hogan purchased 7,576 shares of the company’s stock in a transaction on Friday, August 1st. The shares were bought at an average cost of $131.49 per share, with a total value of $996,168.24. Following the transaction, the chief executive officer directly owned 184,945 shares in the company, valued at approximately $24,318,418.05. This represents a 4.27% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.66% of the stock is currently owned by corporate insiders.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.